Digestive Tolerance of Slightly Hydrolyzed Starter Infant Formula With Probiotics
Tolerance of a Slightly Hydrolyzed Starter Formula Containing Probiotics
1 other identifier
interventional
480
1 country
1
Brief Summary
To demonstrate that infants have improved gut comfort when fed a slightly hydrolyzed starter formula containing probiotics compared to infants fed a control hydrolyzed and referenced non-hydrolyzed formula.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2009
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2009
CompletedFirst Submitted
Initial submission to the registry
December 17, 2009
CompletedFirst Posted
Study publicly available on registry
December 21, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2012
CompletedJune 22, 2012
June 1, 2012
2.1 years
December 17, 2009
June 21, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incidence of crying/fussing from 1 to 3 months.
3 months
Secondary Outcomes (1)
growth and night sleep
6 months
Study Arms (4)
Test formula 1
EXPERIMENTALHydrolyzed formula with probiotics
test formula 2
ACTIVE COMPARATORacidified hydrolyzed formula.
Test formula 3
ACTIVE COMPARATORhydrolyzed formula without probiotics
reference product
ACTIVE COMPARATORstandard infant formula
Interventions
hydrolyzed formula with probiotics
acidified hydrolyzed formula
hydrolyzed formula without probiotics
standard infant formula
Eligibility Criteria
You may qualify if:
- Healthy infants, 0-1 month old at point of enrollment
- Birth weight \< 2500g and \> 4500g
- Gestational age \< 37 weeks and \> 42 weeks
- Infants who cannot be breastfed because of the maternal status
- Willing to exclusively consume the assigned study formula with whey protein
- Are likely to be compliant
- Mother/caregiver demonstrates an understanding of the given information and ability to record the requested data
You may not qualify if:
- Congenital illness or malformation
- Significant pre-natal and/or post-natal disease
- Receiving systemic antibiotic treatment at time of enrolment
- Infant with symptoms of allergy to cow's milk
- Infant's family cannot be expected to comply with treatment (feeding regimen)
- Subjects who cannot be expected to comply with treatment
- Currently participating or having participated in another clinical trial during the last month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Société des Produits Nestlé (SPN)lead
- Chulalongkorn Universitycollaborator
Study Sites (1)
Chulalongkorn University
Bangkok, Thailand
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
A/Prof. Boosba Vivatvakin, MD
Pediatric Gastroenterology Unit,Faculty of Medicine, Chulalongkorn University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 17, 2009
First Posted
December 21, 2009
Study Start
December 1, 2009
Primary Completion
January 1, 2012
Study Completion
April 1, 2012
Last Updated
June 22, 2012
Record last verified: 2012-06